MedTrace Logo

Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)

NCT06625736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-10-03

No results posted yet for this study

Summary

The study investigates the effectiveness of the natural product Dandelion in treating obesity in premenopausal women through a randomized interventional trial, measuring various parameters and biomarkers.

Conditions

  • Obese Women
  • Perimenopause

Interventions

DRUG

Xenical

The Xenical group will receive identical capsules 120mg (one capsule) to be taken three times daily with meals, equaling 360mg total daily dose, which aligns with the usage in adult female patients

DIETARY_SUPPLEMENT

The dandelion extract

The dandelion extract group will receive 500 mg capsules of dandelion leaf extract, given 3 times per day before meals.

Sponsors & Collaborators

  • Pharos University in Alexandria

    collaborator OTHER

  • October 6 University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-05
Primary Completion
2024-09-07
Completion
2024-09-07

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06625736 on ClinicalTrials.gov